by Tim Daly | Feb 22, 2017 | Blog, Skin Cancer
When assessing the risk of a mole, we all know the traditional ABCDE’s (check out the American Academy of Dermatologists here if you don’t). Dermatologists bring an even greater level of sophistication when they assess a mole’s features. However, this is notoriously...
by Tim Daly | Feb 18, 2017 | Blog, Skin Cancer
It’s All About Depth. At Skin Analytics we put all our energy into catching melanoma early. But why? Because if a melanoma grow just a fraction of a millimetre too deep, its much harder to stop. Before we talk about why that is, lets get into some biology....
by Tim Daly | Jul 28, 2016 | Blog, Skin Cancer
“There’s not enough evidence to weigh the benefits and harms of performing routine visual examinations to screen for skin cancer.” This is the conclusion from the U.S. Preventive Services Task Force in a recently concluded review of screening. But not everyone agrees...
by Tim Daly | Oct 9, 2015 | Blog, Skin Cancer
Here in London we’ve noticed it getting a little chillier over the last couple of weeks. Winter coats are coming out and central heating is going on. But we also know summer’s over because our summer surge of site visits is starting to drop off. We always get a peak...
by Tim Daly | Aug 15, 2015 | Blog, Skin Cancer
Melanoma is one of the fastest growing cancers in the world and it disproportionately affects young people. Current global survival rates are up at around 75%. That’s good, but until it’s 100%, we need to do better. So where do we start? Melanoma, like any cancer, can...
by Tim Daly | Aug 10, 2015 | Blog, Skin Cancer
Cancer Research UK’s latest report sheds a stark light on the importance of early diagnosis. Across 8 common cancers, including melanoma, 10 year survival was up at 81% for those caught at stage 1 and 2 but fell sharply to 26% for those caught at stages 3 and 4....
